General Catalyst Group Management, LLC

General Catalyst Group Management, LLC reported 13 holdings worth US$478M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

General Catalyst Group Management, LLC reported 13 holdings worth US$478M as of Sep 30, 2026. Largest: QUALCOMM Incorporated, Parabilis Medicines, Inc. and ArriVent BioPharma, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
13
Value as reported
US$478M

The filing in full

CompanySharesValue as reported% of portfolio
QUALCOMM Incorporated1.58MUS$291M60.9%
Parabilis Medicines, Inc.1.6MUS$51.7M10.8%
ArriVent BioPharma, Inc.1.49MUS$45.3M9.5%
Maplebear Inc.711KUS$30.6M6.4%
Maze Therapeutics, Inc.1.04MUS$28.2M5.9%
Odyssey Therapeutics, Inc.810KUS$18M3.8%
Oscar Health, Inc.300KUS$9.25M1.9%
Coupang, Inc.79,177US$1.1M0.23%
Meta Platforms, Inc.1,320US$957K0.20%
Amazon.com, Inc.3,532US$880K0.18%
Carvana Co.8,765US$548K0.11%
DoorDash, Inc.1,300US$239K0.05%
Martin Marietta Materials, Inc.175US$83,9670.02%
Fractyl Health, Inc.0US$00.00%
Eikon Therapeutics, Inc.0US$00.00%
Ethos Technologies Inc.0US$00.00%
Figma Inc0US$00.00%

Source

Download original · View original at SEC

Related